Atlas Venture Fund VII L P [Rocket]

Date Filed	Type	Description
02/03/2021	SC 13G	Atlas Venture Fund VII L P reports a 6.3% stake in F-star Therapeutics, Inc.
02/02/2021	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2020	SC 13G/A	Atlas Venture Fund VII L P reports a 9.4% stake in ZAFGEN, INC.
02/08/2019	SC 13G/A	Atlas Venture Fund VII L P reports a 9.4% stake in ZAFGEN, INC.
02/09/2018	SC 13G/A	Atlas Venture Fund VII L P reports a 16.8% stake in ZAFGEN, INC.
02/09/2018	SC 13G/A	Atlas Venture Fund VII L P reports a 6% stake in EGALET CORPORATION
02/23/2017	SC 13D	Atlas Venture Fund VII L P reports a 14.8% stake in MIRAGEN THERAPEUTICS, INC.
02/09/2017	SC 13G/A	Atlas Venture Fund VII L P reports a 16.9% stake in ZAFGEN, INC.
02/09/2017	SC 13G/A	Atlas Venture Fund VII L P reports a 10.2% stake in EGALET CORPORATION
02/12/2016	SC 13G/A	Atlas Venture Fund VII L P reports a 17% stake in ZAFGEN, INC.
02/12/2016	SC 13G/A	Atlas Venture Fund VII L P reports a 10.2% stake in EGALET CORPORATION
02/12/2015	SC 13G	Atlas Venture Fund VII L P reports a 14% stake in EGALET CORPORATION
02/12/2015	SC 13G	Atlas Venture Fund VII L P reports a 24.8% stake in ZAFGEN, INC.
02/13/2014	SC 13G/A	Atlas Venture Fund VII L P has filed a Schedule 13D for ARCA BIOPHARMA, INC.
02/11/2013	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2012	SC 13G/A	Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/10/2011	SC 13G/A	Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/05/2010	SC 13G/A	Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/10/2009	SC 13G	Form SC 13G -- Statement of acquisition of beneficial ownership by individuals